Purple glove syndrome, the Glossary
Purple glove syndrome (PGS) is a poorly understood skin disease in which the extremities become swollen, discoloured and painful.[1]
Table of Contents
9 relations: Amputation, Edema, Epilepsy, Extravasation, Intravenous therapy, Old age, Peripheral edema, Phenytoin, Skin condition.
- Drug eruptions
Amputation
Amputation is the removal of a limb by trauma, medical illness, or surgery.
See Purple glove syndrome and Amputation
Edema
Edema (AmE), also spelled oedema (BrE), and also known as fluid retention, dropsy, hydropsy and swelling, is the build-up of fluid in the body's tissue.
See Purple glove syndrome and Edema
Epilepsy
Epilepsy is a group of non-communicable neurological disorders characterized by recurrent epileptic seizures.
See Purple glove syndrome and Epilepsy
Extravasation is the leakage of a fluid out of its contained space into the surrounding the area, especially blood or blood cells from vessels.
See Purple glove syndrome and Extravasation
Intravenous therapy
Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.
See Purple glove syndrome and Intravenous therapy
Old age
Old age is the range of ages for people nearing and surpassing life expectancy.
See Purple glove syndrome and Old age
Peripheral edema
Peripheral edema is edema (accumulation of fluid causing swelling) in tissues perfused by the peripheral vascular system, usually in the lower limbs.
See Purple glove syndrome and Peripheral edema
Phenytoin
Phenytoin (PHT), sold under the brand name Dilantin among others, is an anti-seizure medication.
See Purple glove syndrome and Phenytoin
Skin condition
A skin condition, also known as cutaneous condition, is any medical condition that affects the integumentary system—the organ system that encloses the body and includes skin, nails, and related muscle and glands. Purple glove syndrome and skin condition are cutaneous conditions.
See Purple glove syndrome and Skin condition
See also
Drug eruptions
- Acne medicamentosa
- Acute generalized exanthematous pustulosis
- Allopurinol hypersensitivity syndrome
- Angioedema
- Anticonvulsant hypersensitivity syndrome
- Application site reaction
- Bromoderma
- Chemotherapy-induced acral erythema
- Chemotherapy-induced hyperpigmentation
- Drug eruption
- Drug rash with eosinophilia and systemic symptoms
- Drug-induced angioedema
- Drug-induced keratoderma
- Drug-induced lupus erythematosus
- Drug-induced pigmentation
- Drug-induced urticaria
- Drug-related gingival hyperplasia
- Erythema multiforme major
- Exudative hyponychial dermatitis
- Fixed drug reaction
- Generalized bullous fixed drug eruption
- HIV disease–related drug reaction
- Halogenoderma
- Heparin necrosis
- Hydroxyurea dermopathy
- Injection site reaction
- Interstitial granulomatous drug reaction
- Iododerma
- Leukotriene receptor antagonist-associated Churg–Strauss syndrome
- Linear IgA bullous dermatosis
- List of SJS-inducing substances
- Livedoid dermatitis
- Mercury poisoning
- Neutrophilic eccrine hidradenitis
- Photoleukomelanodermatitis of Kobori
- Photosensitive drug reaction
- Purple glove syndrome
- Red man syndrome
- Scleroderma-like reaction to taxanes
- Serum sickness-like reaction
- Severe cutaneous adverse reactions
- Steroid acne
- Stevens–Johnson syndrome
- Sulfonamide hypersensitivity syndrome
- Texier's disease
- Toxic epidermal necrolysis
- Urticarial erythema multiforme
- Vitamin K reaction
- Warfarin necrosis